Literature DB >> 15164982

Two different mechanisms of apoptosis resistance observed in interferon-beta induced apoptosis of human glioma cells.

Ryuta Saito1, Masaaki Mizuno, Manabu Hatano, Toshihiro Kumabe, Takashi Yoshimoto, Jun Yoshida.   

Abstract

Interferon (IFN)-beta is known to exert cytostatic or cytocidal effects in human glioma cells and is widely used in the treatment for gliomas. However, precise mechanisms of cell death induced by IFN-beta are not well understood. In this study, the authors investigated the intracellular signal transduction of IFN-beta in human glioma cells. The cell death process observed in susceptible cells SK-MG-1 was accompanied by characteristic morphological changes of apoptosis, processing of caspases, and DNA fragmentation. Use of caspase inhibitors confirmed the activation of caspases, however activated executioner caspase was caspase-7 rather than caspases-3 or -6. Activation of DNA endonuclease, DNase-gamma was also observed. Observation of other IFN-beta relatively resistant glioma cells (U251SP, T98G, U251MG, U87MG, SK-AO2) revealed two different mechanisms of apoptosis resistance. In contrast to T98G, U87MG, and SK-AO2 which showed no activation of caspases, surprisingly, all the apoptosis process except DNase-gamma activation was observed in U251SP and U251MG cells. Collectively, these findings indicate that IFN-beta induced apoptosis in human glioma cells through activation of caspase-7 and activation of DNase-gamma. The similar activations of caspases were found also in some of the apoptosis resistant cells. These findings may help to improve the IFN-beta therapy in near future.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15164982     DOI: 10.1023/b:neon.0000024217.68738.11

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  17 in total

1.  Process of apoptosis induced by TNF-alpha in murine fibroblast Ltk-cells: continuous observation with video enhanced contrast microscopy.

Authors:  K Okamoto; M Mizuno; N Nakahara; A Natsume; J Yoshida; T Mori; S Hori; H Kobayashi
Journal:  Apoptosis       Date:  2002-02       Impact factor: 4.677

2.  Apoptotic DNA endonuclease (DNase-gamma) gene transfer induces cell death accompanying DNA fragmentation in human glioma cells.

Authors:  Ryuta Saito; Masaaki Mizuno; Toshihiro Kumabe; Takashi Yoshimoto; Sei-ichi Tanuma; Jun Yoshida
Journal:  J Neurooncol       Date:  2003-05       Impact factor: 4.130

3.  Apoptosis in the absence of caspase 3.

Authors:  Y Liang; C Yan; N F Schor
Journal:  Oncogene       Date:  2001-10-04       Impact factor: 9.867

4.  Fas-mediated apoptosis in human prostatic carcinoma cell lines occurs via activation of caspase-8 and caspase-7.

Authors:  O W Rokhlin; R A Glover; M B Cohen
Journal:  Cancer Res       Date:  1998-12-15       Impact factor: 12.701

Review 5.  Apoptosis by death factor.

Authors:  S Nagata
Journal:  Cell       Date:  1997-02-07       Impact factor: 41.582

6.  Block of glioma cell line in S by interferon.

Authors:  D Lundblad; E Lundgren
Journal:  Int J Cancer       Date:  1981-06-15       Impact factor: 7.396

7.  National survey of patterns of care for brain-tumor patients.

Authors:  M S Mahaley; C Mettlin; N Natarajan; E R Laws; B B Peace
Journal:  J Neurosurg       Date:  1989-12       Impact factor: 5.115

Review 8.  Dysregulation of apoptosis in cancer.

Authors:  J C Reed
Journal:  J Clin Oncol       Date:  1999-09       Impact factor: 44.544

9.  Inositol hexakisphosphate kinase 2 mediates growth suppressive and apoptotic effects of interferon-beta in ovarian carcinoma cells.

Authors:  B H Morrison; J A Bauer; D V Kalvakolanu; D J Lindner
Journal:  J Biol Chem       Date:  2001-05-03       Impact factor: 5.157

Review 10.  Apoptosis and interferons: role of interferon-stimulated genes as mediators of apoptosis.

Authors:  M Chawla-Sarkar; D J Lindner; Y-F Liu; B R Williams; G C Sen; R H Silverman; E C Borden
Journal:  Apoptosis       Date:  2003-06       Impact factor: 4.677

View more
  9 in total

1.  Interferon-β and temozolomide combination therapy for temozolomide monotherapy-refractory malignant gliomas.

Authors:  Hiroshi Kawaji; Tsutomu Tokuyama; Tomohiro Yamasaki; Shinji Amano; Naoto Sakai; Hiroki Namba
Journal:  Mol Clin Oncol       Date:  2015-04-08

2.  Bcl2L12 inhibits post-mitochondrial apoptosis signaling in glioblastoma.

Authors:  Alexander H Stegh; Hyunggee Kim; Robert M Bachoo; Kristin L Forloney; Jean Zhang; Harald Schulze; Kevin Park; Gregory J Hannon; Junying Yuan; David N Louis; Ronald A DePinho; Lynda Chin
Journal:  Genes Dev       Date:  2007-01-01       Impact factor: 11.361

3.  Tumor Resection Recruits Effector T Cells and Boosts Therapeutic Efficacy of Encapsulated Stem Cells Expressing IFNβ in Glioblastomas.

Authors:  Sung Hugh Choi; Daniel W Stuckey; Sara Pignatta; Clemens Reinshagen; Jasneet Kaur Khalsa; Nicolaas Roozendaal; Jordi Martinez-Quintanilla; Kaoru Tamura; Erhan Keles; Khalid Shah
Journal:  Clin Cancer Res       Date:  2017-09-14       Impact factor: 12.531

4.  Suppression of autophagy enhanced growth inhibition and apoptosis of interferon-β in human glioma cells.

Authors:  Yubin Li; Haiyan Zhu; Xian Zeng; Jiajun Fan; Xiaolu Qian; Shaofei Wang; Ziyu Wang; Yun Sun; Xiaodan Wang; Weiwu Wang; Dianwen Ju
Journal:  Mol Neurobiol       Date:  2013-01-18       Impact factor: 5.590

5.  Evaluating the effect of therapeutic stem cells on TRAIL resistant and sensitive medulloblastomas.

Authors:  Irina Nesterenko; Simone Wanningen; Tugba Bagci-Onder; Maarten Anderegg; Khalid Shah
Journal:  PLoS One       Date:  2012-11-07       Impact factor: 3.240

6.  Antitumorigenic effect of interferon-β by inhibition of undifferentiated glioblastoma cells.

Authors:  Shun Yamamuro; Emiko Sano; Yutaka Okamoto; Yushi Ochiai; Takashi Ohta; Akiyoshi Ogino; Atsushi Natsume; Toshihiko Wakabayashi; Takuya Ueda; Hiroyuki Hara; Tomohiro Nakayama; Atsuo Yoshino; Yoichi Katayama
Journal:  Int J Oncol       Date:  2015-09-14       Impact factor: 5.650

Review 7.  Convection-enhanced Delivery of Therapeutics for Malignant Gliomas.

Authors:  Ryuta Saito; Teiji Tominaga
Journal:  Neurol Med Chir (Tokyo)       Date:  2016-12-15       Impact factor: 1.742

8.  ATR Inhibition Induces CDK1-SPOP Signaling and Enhances Anti-PD-L1 Cytotoxicity in Prostate Cancer.

Authors:  Patrick G Pilié; Chuandong Geng; Zhe Tang; Ganiraju C Manyam; Guang Yang; Sanghee Park; Daoqi Wang; Shan Peng; Cheng Wu; Guang Peng; Timothy A Yap; Paul G Corn; Bradley M Broom; Timothy C Thompson
Journal:  Clin Cancer Res       Date:  2021-06-24       Impact factor: 12.531

9.  Antitumor effects of ribavirin in combination with TMZ and IFN-β in malignant glioma cells.

Authors:  Yushi Ochiai; Koichiro Sumi; Emiko Sano; Sodai Yoshimura; Shun Yamamuro; Akiyoshi Ogino; Takuya Ueda; Yutaka Suzuki; Tomohiro Nakayama; Hiroyuki Hara; Yoichi Katayama; Atsuo Yoshino
Journal:  Oncol Lett       Date:  2020-08-31       Impact factor: 2.967

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.